NASDAQ
Drugs Made In America Acquisition II Corp. - Unit (DMIIU)
♥ 606 Thanks from members
Drugs Made In America Acquisition II Corp. (DMIIU) reflects strong structural interest around its $500M pharmaceutical reshoring trust, offset by tight operating liquidity, governance hurdles, and a recent CEO resignation linked to sponsor overpayments.
No chart available for this instrument.